These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2408237)
21. [Experimental studies on the rheologic behavior of blood in ultraviolet therapy]. Bäumler H; Lerche D; Scherf HP; Bilsing R; Meier W; Kucera W; Wiesner S Z Gesamte Inn Med; 1982 Jul; 37(14):458-65. PubMed ID: 7136090 [TBL] [Abstract][Full Text] [Related]
22. [Changes of blood-flow and erythrocyte properties in arterial occlusive diseases]. Ehrly AM Med Welt; 1975 Oct; 26(43):1971-2. PubMed ID: 1196088 [No Abstract] [Full Text] [Related]
23. [The use of physical factors in treating chronic arterial insufficiency of the lower limbs]. Dovganiuk AP; Minenkov AA Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):7-9. PubMed ID: 9036675 [No Abstract] [Full Text] [Related]
24. A mathematical model for blood flow through an arterial bifurcation. Tandon PN; Kawahara M; Rana UV Int J Biomed Comput; 1994 May; 35(4):309-25. PubMed ID: 8063457 [TBL] [Abstract][Full Text] [Related]
25. [The physiotherapy of obliterating vascular diseases of the lower extremities]. Orzheshkovskiĭ VV; Kryzhanovskaia NV Med Sestra; 1991 Jul; 50(7):27-30. PubMed ID: 1758280 [No Abstract] [Full Text] [Related]
26. [MR-Imaging of lower leg muscle perfusion]. Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340 [TBL] [Abstract][Full Text] [Related]
27. Effect of hormone replacement therapy upon haemorheological variables. Spengler MI; Goñi GM; Mengarelli G; Bravo Luna M; Bocanera R; Tozzini R; Rasia ML Clin Hemorheol Microcirc; 2003; 28(1):13-9. PubMed ID: 12632008 [TBL] [Abstract][Full Text] [Related]
28. [Flow characteristics of blood and its therapeutic modification]. Reinhart WH Schweiz Med Wochenschr; 1987 May; 117(18):693-7. PubMed ID: 3589626 [TBL] [Abstract][Full Text] [Related]
29. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs]. Runge E; Thiele P Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891 [TBL] [Abstract][Full Text] [Related]
30. [Interactions between vascular endothelium and blood rheology]. Leschke M; Strauer BE Verh Dtsch Ges Inn Med; 1991; 97():511-5. PubMed ID: 1808936 [No Abstract] [Full Text] [Related]
31. [The use of therapeutic physical factors in obliterating diseases of the peripheral arteries]. Ulashchik VS; Khapaliuk NG Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (4):58-64. PubMed ID: 1792733 [No Abstract] [Full Text] [Related]
32. [Effect of vincamine on blood viscosity]. Ehrly AM; Landgraf H Fortschr Med; 1982 May; 100(20):969-71. PubMed ID: 7095712 [TBL] [Abstract][Full Text] [Related]
33. [Simulation analysis in hemorheology (author's transl)]. Azuma T; Fukushima T; Matsuzawa T Iyodenshi To Seitai Kogaku; 1981 Dec; 19(7):480-8. PubMed ID: 7047810 [No Abstract] [Full Text] [Related]
34. [Therapeutic consequences of hemorheologic research]. Ernst E Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217 [TBL] [Abstract][Full Text] [Related]
35. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies]. Mozzi E; Annoni F; Chiurazzi D; Rossi R; Pacini F; Martini A Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499 [No Abstract] [Full Text] [Related]
36. [The flow properties of blood and their clinical significance in the arterial vascular patient]. Kiesewetter H; Jung F; Spitzer S; Wenzel E Internist (Berl); 1989 Jul; 30(7):420-8. PubMed ID: 2670809 [No Abstract] [Full Text] [Related]
37. Rheological changes after stenting of a cerebral aneurysm: a finite element modeling approach. Ohta M; Wetzel SG; Dantan P; Bachelet C; Lovblad KO; Yilmaz H; Flaud P; Rüfenacht DA Cardiovasc Intervent Radiol; 2005; 28(6):768-72. PubMed ID: 16184328 [TBL] [Abstract][Full Text] [Related]
38. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases]. Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022 [TBL] [Abstract][Full Text] [Related]
39. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940 [TBL] [Abstract][Full Text] [Related]
40. Some flow properties of erythrocytes and rouleaux. Goldsmith HL Bibl Anat; 1967; 9():259-65. PubMed ID: 6029874 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]